{
  "abstract": "Amid efforts to reduce opioid exposure, interest in non-opioid pharmacologic therapies has grown. Suzetrigine, also known as Journavx or VX-548, is a novel NaV1.8 sodium channel inhibitor that targets peripheral nociceptors without engaging central opioid pathways.1 Analyses of >300 million patient records found that suzetrigine prescription rates more than doubled between April and August 2025.2 Understanding the questions people are asking and the quality of online information is therefore essential to guide expectations and counseling, as many individuals rely on internet sources to guide treatment decisions and expectations.3 Thus, this study aimed to evaluate the content and quality of publicly available online information regarding suzetrigine.",
  "authors": [
    {
      "affiliations": [
        "Icahn School of Medicine at Mount Sinai, New York, New York, USA",
        "Pain Prevention Research Center, Department of Anesthesiology, Critical Care, & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Renee Ren"
    },
    {
      "affiliations": [
        "Pain Prevention Research Center, Department of Anesthesiology, Critical Care, & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Junying Wang"
    },
    {
      "affiliations": [
        "Pain Prevention Research Center, Department of Anesthesiology, Critical Care, & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Tina Chen"
    },
    {
      "affiliations": [
        "Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA"
      ],
      "name": "Charles Williams"
    },
    {
      "affiliations": [
        "Department of Anesthesiology Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Maaz Shah Khan"
    },
    {
      "affiliations": [
        "Department of Anesthesiology Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Meghan Kirksey"
    },
    {
      "affiliations": [
        "Department of Anesthesiology Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Daniel Maalouf"
    },
    {
      "affiliations": [
        "Pain Prevention Research Center, Department of Anesthesiology, Critical Care, & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Jashvant Poeran"
    },
    {
      "affiliations": [
        "Pain Prevention Research Center, Department of Anesthesiology, Critical Care, & Pain Management, Hospital for Special Surgery, New York, New York, USA"
      ],
      "name": "Alexandra Sideris"
    }
  ],
  "title": "Online questions and information quality surrounding the novel non-opioid analgesic suzetrigine: analysis of publicly available web content",
  "uid": "1a8a7656-20a4-51e9-b6e1-02b82d327de5"
}